STOCKS REGAL Gets Shorted |
SELLAS Life Sciences, a clinical-stage cancer-drug developer, fell Friday after a short report from a firm I have never heard of called BMF circulated around its Phase 3 REGAL leukemia trial. The idea is that participant survivability in the trial SLS fanatics can’t wait to hear about is not that big of a deal. I am not one way or the other on this, just reporting the allegations. Moreover, BMF writes that the nearly $3B market cap vested on this result is betting the result is already great news. |
Remember, short reports generally state they will profit if a stock falls. |
The RIP: $SLS dropped 13.1% to $13.21 on 9.7M shares, roughly its recent volume pace. Reported short interest stood at 56.4M shares, or 27.91% of float, as of August 14. That delayed figure shows crowded positioning, not proof that shorts drove Friday’s move. |
REGAL remained at 78 of the 80 events needed to trigger its final analysis in the latest company update. Until that update, one of Stocktwits’ loudest retail communities will have to keep waiting. |
The Community Read: The room split nearly down the middle as REGAL anxiety returned -> |
“$SLS I'm back after my 2 day timeout. Sold 20% of my position yesterday.” @I_Buy_Stock |
|
|
“$SLS when the SP hit $100 i will unblock all the bears” @elden_ring |
|
|
AI’s Financing Bill Arrives |
Nvidia’s new role as banker to the AI boom hit a snag Friday. The Wall Street Journal reported that the chipmaker paused some cloud revenue-sharing deals over partner pushback and antitrust concerns, though Nvidia said the broader program remains active and continues to evolve. |
The RIP: $NVDA fell 4.6%, while $IREN, $APLD, and $BRUN dropped 12.5%, 7.7%, and 17.3%. Neither $APLD nor $BRUN was identified as part of the paused deals, making their declines sector read-throughs rather than confirmed contract hits. |
IREN supplied the actual financing bill with its earnings report. Quarterly revenue slipped to $137.2M from $144.8M, and adjusted EBITDA fell to $19.2M from $59.5M as the company retired Bitcoin miners and built out its cloud platform. This we already know. Nvidia and Co. championed their AI company spending spree during their Wednesday report, as the CFO said it was great picks to invest in the future. They bought 30M shares of IREN at $70/each in May. |
The feeling on Friday, with rate increase talks, was yeah right, we’ll believe it when we see it. 🧾 |
The Community Read: The bullish IREN room is betting execution outruns the financing bill -> |
“They are paying for a cloud company that doesn't have its revenue yet.” @KavaStocks |
|
|
“$NVDA insane earnings report is worth 1 day of gains followed by no one remembering the next day.” @Greenzombie04 |
|
|